Nanoparticles inhibit cancer cell invasion and enhance antitumor efficiency by targeted drug delivery via cell surface-related GRP78

References

• KumarVToffoliGRizzolioFFluorescent carbon nanoparticles in medicine for cancer therapyACS Med Chem Lett20134111012101324936239
   PubMed Web of Science ®Google Scholar
• WangCRaviSGarapatiUSMultifunctional chitosan magnetic-graphene (CMG) nanoparticles: a theranostic platform for tumor-targeted co-delivery of drugs, genes and MRI contrast agentsJ Mater Chem B Mater Biol Med20131354396440524883188
   PubMed Web of Science ®Google Scholar
• XuHHouZZhangHAn efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(ε-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasionInt J Nanomedicine2014923124224403829
   PubMed Web of Science ®Google Scholar
• DengZJMortonSWBen-AkivaEDreadenECShopsowitzKEHammondPTLayer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatmentACS Nano20137119571958424144228
   PubMed Web of Science ®Google Scholar
• FriedmanHHoltATPhamWLipid nanoparticles as ideal delivery modules for siRNANanomedicine (Lond)201381219101911
   Google Scholar
• MiaoQXuDWangZAmphiphilic hyper-branched co-polymer nanoparticles for the controlled delivery of anti-tumor agentsBiomaterials201031287364737520599267
   PubMed Web of Science ®Google Scholar
• LiXQinFYangLMoLLiLHouLSulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinomaInt J Nanomedicine201493971398525170267
   PubMed Web of Science ®Google Scholar
• YangJHuangYGaoCLiuMZhangXFabrication and evaluation of the novel reduction-sensitive starch nanoparticles for controlled drug releaseColloids Surf B Biointerfaces201411536837624463097
   PubMed Web of Science ®Google Scholar
• RagelleHRivaRVandermeulenGChitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiencyJ Control Release2014176546324389132
   PubMed Web of Science ®Google Scholar
• YuZSchmaltzRMBozemanTCSelective tumor cell targeting by the disaccharide moiety of bleomycinJ Am Chem Soc201313582883288623379863
   PubMed Web of Science ®Google Scholar
• SunLWeiZChenHFolic acid-functionalized up-conversion nanoparticles: toxicity studies in vivo and in vitro and targeted imaging applicationsNanoscale20146158878888324961224
   PubMed Web of Science ®Google Scholar
• YuanYZhangJAnLCaoQDengYLiangGOligomeric nanoparticles functionalized with NIR-emitting CdTe/CdS QDs and folate for tumor-targeted imagingBiomaterials201435277881788624952975
   PubMed Web of Science ®Google Scholar
• LiuTKempsonIde JongeMHowardDLThierryBQuantitative synchrotron X-ray fluorescence study of the penetration of transferrin-conjugated gold nanoparticles inside model tumour tissuesNanoscale20146169774978225008536
   PubMed Web of Science ®Google Scholar
• WuLCChuLWLoLWLiaoYCWangYCYangCSProgrammable cellular retention of nanoparticles by replacing the synergistic anion of transferrinACS Nano20137136537523194060
   PubMed Web of Science ®Google Scholar
• ShiraziANPaquinKLHowlettNGMandalDParangKCyclic peptide-capped gold nanoparticles for enhanced siRNA deliveryMolecules2014199133191333125170952
   PubMed Web of Science ®Google Scholar
• JiangTYuXCarboneEJNelsonCKanHMLoKWPoly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applicationsInt J Pharm20144751–254755725194353
   PubMedGoogle Scholar
• ZhangHLvMZhaoZGlucose-regulated protein 78 may play a crucial role in promoting the pulmonary microvascular remodeling in a rat model of hepatopulmonary syndromeGene2014545115616224768185
   PubMed Web of Science ®Google Scholar
• DelieFPetignatPCohenMGRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78Target Oncol20138422523023090204
   PubMed Web of Science ®Google Scholar
• DelieFPetignatPCohenMGRP78 protein expression in ovarian cancer patients and perspectives for a drug-targeting approachJ Oncol2012201246861522481929
   PubMedGoogle Scholar
• LiuYSteinigerSCKimYKaufmannGFFelding-HabermannBJandaKDMechanistic studies of a peptidic GRP78 ligand for cancer cell-specific drug deliveryMol Pharm20074343544717373820
   PubMed Web of Science ®Google Scholar
• LiZWangYWuHZhangLYangPLiZGRP78 enhances the glutamine metabolism to support cell survival from glucose deficiency by modulating the β-catenin signalingOncotarget20145145369538024977433
   PubMedGoogle Scholar
• YangLYangSLiuJExpression of GRP78 predicts taxane-based therapeutic resistance and recurrence of human gastric cancerExp Mol Pathol201496223524124602846
   PubMed Web of Science ®Google Scholar
• GuoYSSunZMaJ17β-Estradiol inhibits ER stress-induced apoptosis through promotion of TFII-I-dependent Grp78 induction in osteoblastsLab Invest201494890691624933421
   PubMed Web of Science ®Google Scholar
• SuRLiZLiHGrp78 promotes the invasion of hepatocellular carcinomaBMC Cancer2010102020082722
   PubMed Web of Science ®Google Scholar
• ZhangDTaiLKWongLLProteomic characterization of differentially expressed proteins in breast cancer: expression of hnRNP H1, RKIP and GRP78 is strongly associated with HER-2/neu statusProteomics Clin Appl2008219910721136783
   PubMed Web of Science ®Google Scholar
• MisraUKPizzoSVReceptor-recognized α2-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cellsPLoS One2012712e5173523272152
   PubMed Web of Science ®Google Scholar
• LiuRLiXGaoWMonoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasisClin Cancer Res201319246802681124048331
   PubMed Web of Science ®Google Scholar
• ZhangXXLiHDZhaoSThe cell surface GRP78 facilitates the invasion of hepatocellular carcinoma cellsBiomed Res Int2013201391729624383061
   PubMed Web of Science ®Google Scholar
• LiZZhangLZhaoYCell-surface GRP78 facilitates colorectal cancer cell migration and invasionInt J Biochem Cell Biol201345598799423485528
   PubMed Web of Science ®Google Scholar
• MiaoYREckhardtBLCaoYInhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78Clin Cancer Res20131982107211623470966
   PubMed Web of Science ®Google Scholar
• RaiterAVilkinAGingoldRThe presence of anti-GRP78 antibodies in the serum of patients with colorectal carcinoma: a potential biomarker for early cancer detectionInt J Biol Markers Epub201451
   Web of Science ®Google Scholar
• ChenMZhangYYuVCChongYSYoshiokaTGeRIsthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunctionCell Death Differ201421579781024464222
   PubMed Web of Science ®Google Scholar
• KangJZhaoGLinTA peptide derived from phage display library exhibits anti-tumor activity by targeting GRP78 in gastric cancer multidrug resistance cellsCancer Lett2013339224725923792224
   PubMed Web of Science ®Google Scholar
• WangQLiuPGongTSunXDuanYZhangZUptake mechanism and endosomal fate of drug-phospholipid lipid nanoparticles in subcutaneous and in situ hepatomaJ Biomed Nanotechnol2014106993100324749394
   PubMed Web of Science ®Google Scholar
• GaoHYangZZhangSPangZJiangXInternalization and subcellular fate of aptamer and peptide dual-functioned nanoparticlesJ Drug Target201422545045924512500
   PubMed Web of Science ®Google Scholar
• HeXLiJAnSJiangCpH-sensitive drug-delivery systems for tumor targetingTher Deliv20134121499151024304248
   PubMedGoogle Scholar
• KocbekPKraljSKreftMEKristlJTargeting intracellular compartments by magnetic polymeric nanoparticlesEur J Pharm Sci201350113013823603023
   PubMed Web of Science ®Google Scholar
• ZhaoLSuRCuiWShiYLiuLSuCPreparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediationInt J Nanomedicine201492149215624851048
   PubMed Web of Science ®Google Scholar
• SongHSuCCuiWFolic acid-chitosan conjugated nanoparticles for improving tumor-targeted drug deliveryBiomed Res Int2013201372315824282819
   PubMed Web of Science ®Google Scholar
• SuCLiHShiYCarboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acidInt J Pharm20144741–220221125149123
   PubMedGoogle Scholar